For adults with diabetes and obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for obesity-related cancer compared with dipeptidyl peptidase-4 (DPP-4) ...

The top US health agency will no longer recommend the COVID-19 vaccine for healthy children and pregnant women.

Evidence suggests repeated low-level red light therapy for pediatric myopia management may risk cone photoreceptor loss.

Patients with glaucoma often demonstrate poor adherence to prescribed treatment plans with prostaglandin analogues, which decreases over time.

Patients with respiratory syncytial virus (RSV) hospitalization have increased odds of any acute cardiovascular event compared with COVID-19 hospitalizations.

Health officials at the World Health Organization are warning of a rise in cases from a new COVID-19 variant. The new variant, NB.1.8.1, has been spotted in the ...

Epi-on demonstrates a more favorable safety profile than epi-off corneal cross-linking in patients with corneal ectasia.

Compared with single-vision lens wear, 2 years of orthokeratology lens wear can slow axial elongation for at least 11 years ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic retinopathy who have previously responded to at least 2 intravitreal ...

Dry eye disease metrics, such as NIBUT and MG dropout, may serve as predictive biomarkers for possible thyroid disorders.

GLP-1 agonists may help reduce acetazolamide dosage in patients with idiopathic intracranial hypertension without changing clinical outcome.